OMB 0651-0032 U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.

(Onlyfor new nonprovisional applications under 37 CFR 1.53(b)) Priority Mail Express ® Label No.

The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application.

‘ 37 CFR 3.73(C) Statement (when there is an assignee) Power of Attorney English Translation Document (ifapplicable) Information Disclosure Statement (PTO/SB/08 or PTO-1449) |:' Copies of Citations attached Preliminary Amendment Return Receipt Postcard (MPEP § 503) (Should be specifically itemized) Certified Copy of Priority Document(s) (ifforeign priority is claimed)

Other: Authorization to Treat a Reply as Incorporating an Extension of Time Under 37 C.F.R. § 1.136(a)(3); ASCII text file of Sequence Listing

Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, US.

and tr: transactat: bustr1333 irt the United States Patant and Tradémark (3111119 mnnactaa’ tharewith fer the appticatien referencsd in the \‘attg‘iéttehd transmitt-a1 letter (farm PTC/AEA’EZA) 0r ic‘entitted abova: err hereby appaint Practittcnerts) named in the attached 1151 (term PTQ/AtA/azc) as my/crur attnmews) er agenfls), and tr: trafisact alt business in the United States Patent and Trademark Office cannacted therewith far the patent appiicatim referenced in the

{:1 inventrar car Jointmvantcr 111113 r1121 raqutrad betow) E] LegaiRéprésentativa 013 Deceased or Lsgatty incapacitated inventar (titte mt required batsw) {it} Assthse‘ Gr Parson ta Whom the irwarrtar is Under arr Dbttgation to Assign (prcvide signar‘s 11111:: if appticant 15 at 1111131122 antity) [:1 Parsan‘Whe Otherwise Shows sufficient Pruprtstary tatersfi (8.9.31 patitinn under 37 CFR 1.4603112) waa granted in the an .16:61tartar is mmurranti hair» “tried with this dacumant .rcvide aEggrrers 41.1311451163an a ‘uristic 9.4111!

Conflda inciuding gathering praparirig and aubmit‘ting the compstat: app1110a1on term 1:: the USRTC Trme witi vary dapenc’tng upon the individuai case.

Any cammants an the amaunt of time yau requ!r3 to campietes 1111; form and/or suggesticns for redaci.ng thia burden $1191.11at be 36.4113 me Chiaf information OfficanUUS Patant and:Trademark 1311155 U S. Department of"Vern:11616:}.

the TCM frem sanmies '1 1‘3) 63-, and their reiaifiive ieveizi 1'11 pesétive {0111:1111 Bate are greuped according te $.13 Eane mesemed in the me111izsg'ane.

Factcsrs identified with this R3y823 Human: Chemmkina Antibcdy 3:“:3y 1 {Catii AAWCHEfl} in the TCM 5mm sampées 3 and 4-, and 12332;" reiaifiive ieweis m ;::<::::Etive whim: {3:313 are pres-33133 as this 33:3"3 3f the 3131 and gauged amording it: the Earns preseni‘ed Er: 12“:e membrane: 110267 0.00 0.00 0.00 57.44 Taisifi 3‘ £345 geneg {Eiffflrerfitiaiiy expressed in MSC nan-expesed H. mmparisam With aeiis expmsed m TC ' 1.1137 PWPJ‘L homoiog \S.

CD74 molecuie, major hisrocompatibiiity complex, class H invariant chain zinc finger and 8TB domain can aimrig 20 nucl-dr paraspeckie assembly transc.

IdUCGd transmemcrane mate carboxyrnethvleneb; ‘ ase omolag (Pseudorrm SATl 6303 83871 22936 spermidine/spermine N1-acetyitransferase1 RA834, memberRAS oncogene family eiongationfactor RNApolymeraceH

gimaredoxinz heat shock protein 90km aljr' .a (cyiusa!.c;, class A member 1 pmmcadherihboamma subfamil A, 10 necdin—Lke 2 -0.

§ l.57, it‘ a portion of a specification that was inadvertently omitted is present in a prior~filed application to which benefit is claimed, then the benefit claim “shall also he considered an incorporation by reference of the priornliled application as to the inadvertently omitted portion of the specification or drawirig(s)."

These amendments to the specification are believed to introduce no new matter and their entry is respectfully requested.

74, no. 153, pages 40l63—40165 (Aug. ll, 2009),, "[slequence listings that are submitted online through liiili'S—Web in the proper text format do not require a separate CRF copy or the associated statement.” Therefore, Applicant does not Atty.

The Sequence Listing filed herewith by EFSuWEB is believed to intretluee no new matter in accordance with 37 CFR.

Te Be Assigned, mel’ust’nn Prenipt and favorable censideratien (if this Preliminary Amendment is respectfully requested.

DocCode — APPENDIX SCORE Placeholder Sheet for IFW Content Application Number: 15892680 Document Date: 02/09/2018 The presence of this form in the IFW record indicates that the following document type was received in electronic format on the date identified above.

Since this was an electronic submission, there is no physical artifact folder, no artifact folder is recorded in PALM, and no paper documents or physical media exist.

The TIFF images in the IFW record were created from the original documents that are stored in SCORE.

Appendix At the time of document entry (noted above): .

USPTO employees may access SCORE content via eDAN using the Supplemental Content tab, or via the SCORE web page.

Centirmetion Ne: Tn Be Assigned Applicant: CONSELEG 'NACiONAi... DEL

Title: CGMPGSITEGNS AND h’iETHGDS FUR ENCREASENG NEESENCHYREAL SERGE/EAL CELL NEIGRATEON TQ T‘Uh/iflRS Preiiininnry Amendment Untier’ 3’7 QER.

§ LiiS M’nil Stern) Amendment Cnmrnissicner t‘nr Patents PO Bax 1450 Aiexahdria, VA 223 i 3-1450 Commissioner: in advance of presecntien, Applicant submits the feiiewing amendments and; remarks.

Remarks and Arguments begin On page 3 at this paper.

it is not beiieved that extensions of time are required beyond these that may otherwise be provided fer in documents accempanying this paper.

{3335”}?th Power 0‘: Niamey LI‘ 3, Parent and Tradémark Qffice; US DEPARTMENT CF UOMMERCE Under the F’ape ark Fted uctisn Act at 1995, no perSans are recurred to respond to 3 cutiactiarr at inturrrraticn untess it displays a vatid OMB central number

Appiicatian Number Fiiing gate .March 4 149} 6.963 (Nata: Trista bakes above may be left biank if information if; provided on farm PTOIAENESZA.)

buriness In the United Stataes Patent and Trademark Office mnneczted therewih fer the graham asppiicatioh ratarenaad in the attachedtransmitteqi letter (farm PTOI’NNSIEA) c-r idefitified above I’the10e3mpie‘tef9rm PTO/AENESIZC. )

The addrew associated with Custamer‘ Number: Firm or individuai Name inventor er Joint tnhrerrtcr {titie rim rfiquireri beifiw)

:] Legai Repi’eseritatiUe Inf 3 Daceasead or Legaiiy‘ incapacitated inveritm {titia not required beiow) m Assignee or Persoh to Whom the inverrmr is Under an C‘Ibiigaticn to Assign (provide signer's title if appticant is a juristic entity) Persan Who Utherivisa ShawsSufticiem Proprietary interestlie.9.. a patitionIIshder 37 CPR”- 4??

—— Payment information: The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows: —— Fee Worksheet (SBO6) fee—info.pdf c2d81cdcd677ee4748d8dc3f831467ccdf0f df26 Information: Total Files Size (in bytes) This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents, characterized by the applicant, and including page counts, where applicable.

It serves as evidence of receipt similar to a Post Card, as described in MPEP 503.

New Applications Under 35 U.S.C. 111 If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR 1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this Acknowledgement Receipt will establish the filing date of the application.

National Stage of an International Application under 35 U.S.C. 371 If a timely submission to enter the national stage of an international application is compliant with the conditions of 35 U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.

New International Application Filed with the USPTO as a Receiving Office If a new international application is being filed and the international application includes the necessary components for an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of the application.

Substitute for Form PTO-875 Application or Docket Number 15/892,680

(37 CFR1.16(s)) If the specification and drawings exceed 100 sheets of paper, the application size fee due is $310 ($155 for small entity) for each additional 50 sheets or fraction thereof.

16(h)) Application Size Fee (37 CFR1.16(S)) FIRST PRESENTATION OF MULTIPLE DEPENDENT CLAIM (37 CFR1.16(j))

16(h)) Application Size Fee (37 CFR1.16(S)) FIRST PRESENTATION OF MULTIPLE DEPENDENT CLAIM (37 CFR1.16(j))

*** If the ”Highest Number Previously Paid For” IN THIS SPACE is less than 3, enter ”3”.

Substitute for Form PTO—1360 (For use with Form PTO/SB/06) Application Number Filing Date 1 589268 0 Applicant(s) Guillermo MAZZOLI NI * May be used for additional claims or amendments

United States Patent and Trademark Office Address.

Applicant is given TWO MONTHS from the date of this Notice within which to file all required items below to avoid abandonment.

Additional claim fees of $ 1510 as a small entity, including any required multiple dependent claim fee, are required.

The fee(s) required within TWO MONTHS from the date of this Notice to avoid abandonment is/are itemized below.

Replies must be received in the USPTO within the set time period or must include a proper Certificate of Mailing or Transmission under 37 CFR 1.8 with a mailing or transmission date within the set time period.